MultiPlan (Claritev)
- π¦Became a unicorn2020
- πPeak valuation$11 Billion β20
- πBecame a Unitard2022
- πΈLast valuation~$398M
The rise & fall
6 moments Β· 1980β2025The key moments.
How it happened
MultiPlan provides data and analytics that health insurers use to cut medical-claims costs, and went public in October 2020 through an $11B SPAC merger with Michael Klein's Churchill Capital Corp III β one of the largest de-SPAC deals of the era.
Heavy debt, customer-concentration worries and a critical short-seller report battered the stock, which fell nearly 90% from its offering price. The company later rebranded as Claritev and executed a reverse split, leaving its equity worth a small fraction of its debut value.
Glassdoor reviews were middling over many years, with recurring complaints about management, pay and slow advancement.
Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor β. See our methodology.
Source: PE Insights / Claritev / SEC ($11B enterprise value via Churchill Capital Corp III SPAC, Oct 2020; stock -89%+ from offering; rebranded Claritev (CTEV) after a reverse split)
Who ran it
- Travis DaltonChairman, President & CEO of MultiPlan/Claritev (since March 2024, current)
Current roles as self-reported on LinkedIn, retrieved 2026-08-19. See our methodology.
Disclosed investors (4)
Historical funding participation; lists may be incomplete and do not establish current ownership or investor losses.
* Lead in a funding round Β· Crunchbase β Β· 2026-10-13 Β· Methodology Β· Leaderboard
